ArticleAmerican journal of cancer research2022

Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor effects on ovarian clear cell cancer stem-like/spheroid cells by inhibiting the COL6A3-AKT-mTOR pathway.

Chih-Ming Ho et al.PubMed ↗Full text ↗

No numbers read from the abstract.